Ceapro Inc. (CVE:CZO – Get Free Report) shares fell 11.8% on Tuesday. The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares were traded during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The stock has a market cap of C$688,880.00, a P/E ratio of -2.83 and a beta of 1.38. The company has a current ratio of 8.54, a quick ratio of 18.88 and a debt-to-equity ratio of 8.07. The company’s fifty day simple moving average is C$0.22 and its 200-day simple moving average is C$0.23.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Further Reading
- Five stocks we like better than Ceapro
- There’s a New Q in Town: Invesco’s ETF Targets International Innovators
- Boarding Now—GE Aerospace’s Earnings Beat Comes With a Catch
- AI Spending Is Surging—But Which Stocks Still Win if It Slows Down?
- Are RTX Corporation and Northrop Grumman Ready to Break Out?
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
